These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29469081)

  • 1. Statins and risk of cancer: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Kim MK; Myung SK; Tran BT; Park B
    Indian J Cancer; 2017; 54(2):470-477. PubMed ID: 29469081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors.
    Blauw GJ; Lagaay AM; Smelt AH; Westendorp RG
    Stroke; 1997 May; 28(5):946-50. PubMed ID: 9158630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H; Brugts J; Ades T
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.
    Liu J; Zhu LP; Yang XL; Huang HL; Ye DQ
    Bone; 2013 May; 54(1):151-6. PubMed ID: 23388418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
    Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.
    Rahal AJ; ElMallah AI; Poushuju RJ; Itani R
    Saudi Med J; 2016 Oct; 37(10):1051-60. PubMed ID: 27652354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.
    Ott BR; Daiello LA; Dahabreh IJ; Springate BA; Bixby K; Murali M; Trikalinos TA
    J Gen Intern Med; 2015 Mar; 30(3):348-58. PubMed ID: 25575908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.
    Coleman CI; Reinhart K; Kluger J; White CM
    Curr Med Res Opin; 2008 May; 24(5):1359-62. PubMed ID: 18384710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2006 Oct; 24(30):4808-17. PubMed ID: 17001070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Wang Z; Zhang Y; Gao M; Wang J; Wang Q; Wang X; Su L; Hou Y
    Pharmacotherapy; 2011 Nov; 31(11):1051-62. PubMed ID: 22026393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins, low-density lipoprotein cholesterol, and risk of cancer.
    Alsheikh-Ali AA; Trikalinos TA; Kent DM; Karas RH
    J Am Coll Cardiol; 2008 Sep; 52(14):1141-7. PubMed ID: 18804740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and liver toxicity: a meta-analysis.
    de Denus S; Spinler SA; Miller K; Peterson AM
    Pharmacotherapy; 2004 May; 24(5):584-91. PubMed ID: 15162892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up.
    Lv HL; Jin DM; Liu M; Liu YM; Wang JF; Geng DF
    Pharmacol Res; 2014 Mar; 81():64-73. PubMed ID: 24602799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and cancer risk: an epidemiologic review.
    Friis S; Olsen JH
    Cancer Invest; 2006; 24(4):413-24. PubMed ID: 16777695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-TRUST: Long-term risk of cancer in patients under statins therapy. A systematic review and meta-analysis.
    Craveiro NS; Silva Lopes B; Tomás L; Fraga Almeida S; Palma H; Afreixo V; Costa Matos L
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1431-1439. PubMed ID: 31509302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present.
    McClure DL; Valuck RJ; Glanz M; Hokanson JE
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):132-43. PubMed ID: 17072896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxy-3-methylglutaryl-CoA reductase enzyme inhibitors for prevention of contrast-induced nephropathy: a meta-analysis of prospective randomized controlled studies.
    Briasoulis A; Mallikethi-Reddy S; Sharma S; Briasouli AA; Afonso L
    Am J Ther; 2015; 22(6):e158-66. PubMed ID: 25187093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of statin on atrial fibrillation: a meta-analysis of published data from randomized controlled trials.
    Xu Q; Guan YQ; Zhang D; Su GH
    Curr Med Res Opin; 2011 Sep; 27(9):1771-9. PubMed ID: 21806315
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.